Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 25
|
SFEBES2011
|
Next issue
Society for Endocrinology BES 2011
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
Plenary Lecturers’ Biographical Notes
Society for Endocrinology Dale Medal Lecture
Fat, sex hormones and breast cancer
ea0025pl1
Society for Endocrinology Dale Medal Lecture
ea0025pl1biog
Society for Endocrinology Hoffenberg International Medal Lecture
Aldosterone action and the mineralocorticoid receptor
ea0025pl2
Society for Endocrinology Hoffenberg International Medal Lecture
ea0025pl2biog
Society for Endocrinology Transatlantic Medal Lecture
GH, GH receptor antagonists, GH receptor 'knock-outs': a story of fat old mice
ea0025pl3
Society for Endocrinology Transatlantic Medal Lecture
ea0025pl3biog
Society for Endocrinology European Medal Lecture 2010
Adrenocortical carcinoma: advance through international cooperation
ea0025pl4
Society for Endocrinology European Medal Lecture 2010
ea0025pl4biog
Society for Endocrinology European Medal Lecture 2011
Genes and adrenal Cushing's syndrome: advance through European and world networks
ea0025pl5
Society for Endocrinology European Medal Lecture 2011
ea0025pl5biog
Society for Endocrinology Medal Lecture
The bare bones of thyroid hormones
ea0025pl6
Society for Endocrinology Medal Lecture
ea0025pl6biog
The British Thyroid Association Pitt-Rivers Lecture
An expanded view on resistance to thyroid hormone
ea0025pl7
British Thyroid Association Pitt-Rivers Lecture
ea0025pl7biog
Clinical Endocrinology Trust Visiting Professor Lecture
Genetics of thyroid cancer: clinical and therapeutic implications
ea0025pl8
Clinical Endocrinology Trust Visiting Professor Lecture
ea0025pl8biog
Clinical Endocrinology Trust Lecture
Pituitary tumours: the goal is shrinking!
ea0025pl9
Clinical Endocrinology Trust Lecture
ea0025pl9biog
Symposia
All you need to know about the genetics of diabetes (types 1 and 2 and MODY)
Immune mechanisms involved in type 1 diabetes: insights from genetics
ea0025s1.1
The diverse phenotypes of KATP channel mutations
ea0025s1.2
How to find all the cases of MODY in your diabetes clinic...
ea0025s1.3
Genome-wide association studies for type 2 diabetes
ea0025s1.4
Novel pathways and treatments in neuroendocrine tumours
Signaling pathways in neuroendocrine tumors
ea0025s2.1
Integrated genome-wide DNA methylation and mRNA expression analysis of pancreatic NETs
ea0025s2.2
Tyrosine kinase inhibitors for neuroendocrine tumours
ea0025s2.3
New horizons in therapy
ea0025s2.4
Fat endocrinology: disorders of adipose tissue and lipids important to the endocrinologist
Can we make more brown adipose tissue to treat obesity?
ea0025s3.1
Familial partial lipodystrophy: an introduction and the importance of diagnosing FPLD
ea0025s3.2
The link between insulin resistance, dyslipidaemia and fatty liver
ea0025s3.3
What you need to know about the genetics of hyperlipidaemia
ea0025s3.4
Endocrine regulation of ageing
The aging process; somatotropic axis and calorie restriction
ea0025s4.1
The ageing process: insulin signalling and mTOR signalling
ea0025s4.2
Cortisol, DHEAS and immunesenescence
ea0025s4.3
Ageing, hormones and cognition in humans
ea0025s4.4
The novel role of primary cilia in endocrine disease and obesity
Making sense: primary cilia in disease and development
ea0025s5.1
Sonic hedgehog signalling and primary cilia in the adrenal
ea0025s5.2
The importance of primary cilium in adipogenic differentiation
ea0025s5.3
The molecular pathophysiology of the human obesity disorder, Bardet Biedl syndrome (BBS)
ea0025s5.4
Novel application of thyroid hormone analogues: thyroid hormones, thinking outside the capsule
Thyroid hormone action: genomic and non-genomic effects
ea0025s6.1
3-Iodothyronamine: a novel, biologically active thyroid hormone metabolite
ea0025s6.2
The action of thyroid hormone in vascular tissues
ea0025s6.3
Liver: selective TR agonists for the treatment of dyslipidemia
ea0025s6.4
Eat, bond, reproduce – what the hypothalamus dictates
Vasopressin and the olfactory system
ea0025s7.1
The role of tanycytes in the regulation of the reproductive axis
ea0025s7.2
Food or sex: neuropeptides decide
ea0025s7.3
A role for kisspeptin/neurokinin B/dynorphin neurons in initiating and maintaining reproduction
ea0025s7.4
Hormones and bone metabolism
Fracture risk in patients with diabetes
ea0025s8.1
Muscle weakness, falls and vitamin D deficiency
ea0025s8.2
Effects of male hypogonadism on bone metabolism
ea0025s8.3
Protecting bone density during aromatase inhibitor therapy
ea0025s8.4
Doping: performance enhancing substances in sport and their detection
Anabolic steroids in the gym
ea0025s9.1
Compounds enhancing oxygen delivery
ea0025s9.2
Beyond reasonable doubt: catching the GH cheats
ea0025s9.3
Genetic technology in doping and doping detection
ea0025s9.4
Clinical Management Workshops
The management of difficult Graves’ disease
Autoimmune hyperthyroidism: a spectrum of causes
ea0025cm1.1
Thyroid storm, aranulocytosis, vasculitis, hepatitis: what to do next?
ea0025cm1.2
The management of Graves' ophthalmopathy and dermopathy
ea0025cm1.3
New therapies for Graves' disease
ea0025cm1.4
Endocrine problems in pregnancy
Hypothyroidism and euthyroid antibody-positivity in pregnancy
ea0025cm2.1
Treatment of hyperthyroidism in pregnancy: risk for the unborn
ea0025cm2.2
Management of adrenal disorders in pregnancy
ea0025cm2.3
Pituitary disease in pregnancy (including NFPA, prolactinomas, DI)
ea0025cm2.4
Pituitary radiotherapy: what are the options?
Focused radiotherapy as primary treatment for pituitary disease
ea0025cm3.1
Focussed radiotherapy as primary treatment for pituitary disease
ea0025cm3.2
Focused radiotherapy as a salvage treatment for pituitary disease
ea0025cm3.3
Radiotherapy, cognition and cerebrovascular disease: what is the evidence?
ea0025cm3.4
Management of disorders of sex development (DSD) across the lifespan
The clinical spectrum of DSD
ea0025cm4.1
Management of disorders of sex development (DSD) across the lifespan: presentation in adolescence
ea0025cm4.2
Transitional care of the young person with DSD
ea0025cm4.3
New approaches to molecular diagnosis
ea0025cm4.4
Applied Physiology Workshop
Seeing is believing – cutting edge
in vivo
cell imaging
Cellular imaging in the pituitary: in vivo confocal microscopy
ea0025ap1.1
Dynamic imaging of the tumor microenvironment: impact on invasion and CTL effector function
ea0025ap1.2
Quantitative imaging for assessing physical phenotypes in stem cells
ea0025ap1.3
Clinical Guidelines
(1)
Pituitary apoplexy new society guidelines for treatment
ea0025cg1.1
Special Interest Groups
Bone and mineral special interest group
Osteopetrosis and other causes of high bone mass
ea0025sig1.1
Patients teaching doctors: hypophosphatemic rickets and the revelation of a novel phosphate homeostatic system
ea0025sig1.2
Osteogenesis imperfecta
ea0025sig1.3
Osteoporosis
ea0025sig1.4
Obesity special interest group
Gut hormone based polypharmacy: same benefits without the surgery?
ea0025sig2.1
Gut, hormones, weight loss and metabolic improvement after bariatric surgery
ea0025sig2.2
Pre- and post-operative management of patients undergoing bariatric surgery
ea0025sig2.3
Bariatric surgery: a cure for diabetes?
ea0025sig2.4
Laboratory aspects of clinical endocrinology special interest group
Vitamin D deficiency
ea0025sig3.1
Definition of male hypogonadism
ea0025sig3.2
The definition of hypothyroidism
ea0025sig3.3
Definition of hyperandrogenism
ea0025sig3.4
Meet the Expert Sessions
(1)
Abnormal growth and puberty presenting in late adolescence
ea0025mte1
Pitfalls in diagnosis and treatment of Cushing's syndrome
ea0025mte2
The difficult Cushing's or Nelson's patient
ea0025mte3
Managing Turner Syndrome through childhood and adolescence
ea0025mte4
Late effects of cancer therapy
ea0025mte5
Assessing fracture risk and response to therapy in osteoporosis
ea0025mte6
Managing infertility
ea0025mte7
Applications of next generation sequencing: what can a key academic service provider offer?
ea0025mte8
microRNAs - key contributors to endocrinology
ea0025mte9
Nurse Session
Turner/Klinefelter’s/Noonan syndrome: case presentations
Turners/Klinefelters/Noonans syndrome
ea0025n1.1
Klinefelter's case presentation
ea0025n1.2
Living with TS: an adult viewpoint
ea0025n1.3
Klinefelter's Syndrome Association
ea0025n1.4
Hyperthyroidism: case presentations
Hyperthyroidism - overview of causes and treatment options
ea0025n2.1
Nurse-led clinic and hyperthyroidism
ea0025n2.2
Hyperthyroidism - Case presentation
ea0025n2.3
Hyperthyroidism - case presentation
ea0025n2.4
Young Endocrinologists Session
Young endocrinologists’ prize lectures
New insights into glucocorticoid receptor function
ea0025yep1.1
Clinical, genetic and molecular characterisation of patients with familial isolated pituitary adenomas (FIPA)
ea0025yep1.2
A successful research career
Research in clinical academia
ea0025ye1.1
Managing your research career
ea0025ye1.2
Postdoctoral research - the things I wish I knew
ea0025ye1.3
Commercialisation and IP - translating scientific research
ea0025ye1.4
Senior Endocrinologists Session
(1)
The metamorphosis of testosterone from a sex steroid to a universal health factor
ea0025se1.1
Will we ever discover the mechanism of hormone action?
ea0025se1.2
An exploration of colour theory
ea0025se1.3
Two seminal case reports
ea0025se1.4
The art of medicine
ea0025se1.5
The endocrinology of extramarital affairs
ea0025se1.6
Oral Communications
Young Endocrinologists prize session
Thyroid hormones in the euthyroid range predict subsequent body mass composition in women: the OPUS study
ea0025oc1.1
Does 'mild' primary hyperparathyroidism progress if left untreated? A natural history study
ea0025oc1.2
Prolonged exposure to GH impairs insulin signaling in the heart
ea0025oc1.3
Developing an in vitro model of tissue expansion in Graves ophthalmopathy: exploring the role of IGF1 receptor targeting as a novel treatment
ea0025oc1.4
Atheroprotection by 11[beta]-HSD1 deficiency in ApoE-/- mice: role of both glucocorticoid and 7-oxysterol factors
ea0025oc1.5
Evidence for the existence and significance of an alternative pathway towards androgen synthesis during early human life
ea0025oc1.6
Mutant cytochrome b5 causing 46,XY disorder of sex development (DSD) due to apparent CYP17A1 17,20 lyase deficiency
ea0025oc1.7
TSH levels and thyroid hormone prescribing in primary care in the UK
ea0025oc1.8
Steroids
Regulation of 11[beta]-hydroxysteroid dehydrogenase type 1 by NF-[kappa]B in stromal cells: towards tissue specific enzyme inhibition
ea0025oc2.1
Anti-inflammatory mechanisms of 5[alpha]-reduced glucocorticoids: potential dissociated steroids
ea0025oc2.2
APEX1, a novel, negative regulator of aldosterone synthase activity, differentially binds to a single nucleotide polymorphism in the aldosterone synthase gene and represses transcriptional activity both in vitro and in vivo
ea0025oc2.3
Altered miR-125 and miR-134 expression in aldosterone-producing adenoma and post-transcriptional regulation of the CYP11B2 gene
ea0025oc2.4
A novel entity of isolated adrenal insufficiency caused by partial inactivation of P450 side-chain cleavage (CYP11A1) enzyme
ea0025oc2.5
Novel non-steroidal glucocorticoids that dissociate rapid signalling effects from gene transcription
ea0025oc2.6
Depot specific differences in the sensitivity to glucocorticoid and insulin action in human adipose tissue
ea0025oc2.7
Metformin increases in vivo 11[beta]-hydroxysteroid dehydrogenase type 1 activity in euglycaemic obese men
ea0025oc2.8
Pituitary and thyroid
Development of a novel mass spectroscopy-based method for determining serum IGF1: assessment in a cohort of newly diagnosed subjects with acromegaly
ea0025oc3.1
Determination of method-specific normal cortisol responses to the short Synacthen test
ea0025oc3.2
miR-107 inhibits the expression of aryl hydrocarbon receptor interacting protein (AIP) and is potentially involved in pituitary tumorigenesis
ea0025oc3.3
PTTG promotes mitogenic mechanisms in thyroid cells through autocrine pathways of interaction with growth factors
ea0025oc3.4
Metastatic characteristics and radiosensitivity of thyroid carcinoma cells depends on HIF-1 and PI3K signalling in vitro and in vivo
ea0025oc3.5
Morbidity in patients with endogenous subclinical hyperthyroidism
ea0025oc3.6
Thyroid dysfunction and clot structure: a mechanism for increased thrombotic risk in hyperthyroid individuals?
ea0025oc3.7
Assessment of the UK iodine status: a National Survey
ea0025oc3.8
Bone and diabetes
A mouse with an ENU-induced mutation (Tyr209Asn) in the natriuretic peptide receptor 3 (Npr3) develops autosomal recessive kyphosis
ea0025oc4.1
Is Mepe a novel regulator of growth plate mineralisation?
ea0025oc4.2
Rapid bone turnover responses to increased hypothalamic-pituitary-thyroid-axis activity are mediated by thyroid hormones
ea0025oc4.3
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus but not in adipose tissues
ea0025oc4.4
Alterations to hypothalamic 5-HT and DA turnover in offspring induced by maternal exposure to a high caloric diet throughout lactation
ea0025oc4.5
Dual effect of arachidonic acid on peroxisome proliferator-activated receptor [gamma] (PPAR[gamma])-dependent action in 3T3-L1 adipocytes
ea0025oc4.6
Co-administration of the gut hormones PYY and GLP-1 to human volunteers reduces food intake and brain activation in appetite centres
ea0025oc4.7
Hyperghrelinaemia, hyperphagia, food hoarding and reduced adiposity in an imprinting centre deletion mouse model of Prader-Willi syndrome
ea0025oc4.8
Reproduction and fetal programming
The effect of a maternal low protein diet on renal development and function in the offspring
ea0025oc5.1
Maternal low protein diet and fetal growth restriction: new insights into the role of placental 11[beta]-hydroxysteroid dehydrogenase-2
ea0025oc5.2
Mutations in the gene encoding the fibroblast growth factor 8 (FGF8) are associated with complex midline defects including recessive holoprosencephaly and hypothalamo-pituitary dysfunction
ea0025oc5.3
Impaired cardiac function in GR-/- fetal mice
ea0025oc5.4
Absence of 11[beta]-HSD2 specifically within the fetal brain alters adult 'depressive' behaviour
ea0025oc5.5
Consequence of embryonic exposure to 17[beta]-estradiol on brain asymmetry development and neuroendocrine gene expression in Danio rerio
ea0025oc5.6
Plasma biomarkers for early prediction of preeclampsia
ea0025oc5.7
Altered fetoplacental growth in monocarboxylate transporter 8 (Mct8) knockout mice
ea0025oc5.8
Poster Presentations
Bone
Does preoperative localisation for total parthyroidectomy in patients with renal failure improve outcome?
ea0025p1
Influence of age and gender on expression of primary hyperparathyroidism
ea0025p2
Evaluation of the association between serotonin and bone mineral density in patients with neuroendocrine tumours
ea0025p3
Management of hypovitaminosis D in patients with primary hyperparathyroidism
ea0025p4
Risk factors for femoral neck fracture in Indian postmenopausal women (BMD, Vitamin D study and Propensity for a fall)
ea0025p5
Effect of age and gender on bone turnover markers: relationships with oestradiol and parathyroid hormone
ea0025p6
Vitamin D insufficiency in hyperparathyroidism
ea0025p7
Thyrostimulin expression and signalling in the skeleton
ea0025p8
Bone mineral density in patients with primary adrenal insufficiency compared to patients with congenital adrenal hyperplasia
ea0025p9
Serum 25-OH-vitamin D levels in thalassaemia major
ea0025p10
Bone turnover markers in patients on aminobisphosphonate therapy for osteoporosis
ea0025p11
Lithium-induced hypercalcaemia: 'past, present, and future'
ea0025p12
What predicts adverse outcomes in untreated primary hyperparathyroidism?
ea0025p13
A gene causing autosomal dominant kyphoscoliosis in an N-ethyl-N-nitrosourea (ENU) mutagenised mouse model is located on a 5 Mb interval on mouse chromosome 4 band A3
ea0025p14
Parathyroid hormone concentrations in proton pump inhibitor induced hypomagnesaemia
ea0025p15
Radius bone loss with ageing assessed by high-resolution peripheral computed tomography differs in men and women
ea0025p16
A 5'-untranslated region mutation of the growth and differentiation factor 5 (Gdf5) gene increases expression and is associated with decreased urinary excretion of the cartilage degradation product, CTX-II: relevance to osteoarthritis
ea0025p17
The long-term safety and efficacy of zoledronic acid in the treatment of osteoporosis: a 3-year, randomized extension to the HORIZON-pivotal fracture trial (PFT)
ea0025p18
Cervical cord compression in a patient with Paget's disease and primary hyperparathyroidism: a diagnostic challenge
ea0025p19
Localisation studies in primary hyperparathyroidism: our experience
ea0025p20
Co-existing sarcoidosis, primary hyperparathyroidism and vitamin D deficiency in a patient with hypercalcaemia
ea0025p21
Immobility: a rare cause of hypercalcaemia
ea0025p22
Ablation of AMP-activated protein kinase (AMPK) [alpha]1 catalytic subunit in mice leads to decreased bone loss after ovariectomy and impaired bone response to intermittent PTH treatment
ea0025p23
Management of primary hyperparathyroidism
ea0025p24
Comparison of two high dose- bolus vitamin D regimens in women with low vitamin D levels
ea0025p25
Audit of local management of hyperparathyroidism and evaluation of vitamin D deficiency in PHPT
ea0025p26
Clinical biochemistry
A semi-automated method for measuring salivary cortisol and cortisone by tandem mass spectrometry with sample extraction
ea0025p27
25OH vitamin D analysis by liquid chromatography tandem mass spectrometry: interpret results with caution
ea0025p28
Turbulent flow liquid chromatography-tandem mass spectrometry for the analysis of bio-available testosterone in serum
ea0025p29
Recurrent phaeochromocytoma?
ea0025p30
Seasonal variation of vitamin D level among menopausal and postmenopausal saudi women
ea0025p31
Significance of insulin-C-peptide ratio in the diagnostic algorithm for endogenous hyperinsulinaemia
ea0025p32
Cross reactivity of Spironolactone with androstenedione immunoassay
ea0025p33
An unusual case of leg weakness in a patient with diabetes and Addison's disease (Is there a common link?)
ea0025p34
The short Synacthen test (SST): should we be testing at both 30 and 60 min?
ea0025p35
Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11[beta]-hydroxylase inhibitor metyrapone
ea0025p36
Polycythaemia in men treated with transdermal and intramuscular testosterone
ea0025p37
Hypocalcaemia presenting via an acute medical admissions unit is only rarely adequately investigated
ea0025p38
Severe hyponatraemia in pregnancy associated with pre-eclampsia
ea0025p39
Audit of Causes and Consequences of Hyponatraemia in an Inpatient Cohort at a Tertiary Health Centre: Abstract
ea0025p40
Tanned and pregnant-primary adrenal insufficiency during pregnancy
ea0025p41
A review of the Endocrine Transition Service over the last 10 years
ea0025p42
Tolvaptan in a patient with hyponatraemia and a normal chest X-ray
ea0025p43
A case of thyrotropinoma co-secreting FSH and LH
ea0025p44
Audit on the management of adrenal incidentaloma
ea0025p45
A case of Di George's syndrome presenting in late adulthood
ea0025p46
Severe hirsutism of rapid onset in an 81-year-old female
ea0025p47
Hypercortisolaemia in congenital adrenal hyperplasia: a diagnostic dilemma
ea0025p48
Hyponatraemia: the view from primary care
ea0025p49
A clinico-microbiological study of infected diabetic foot ulcers
ea0025p50
A calcium sensing receptor mutation associated with hypercalcaemia and recurrent pancreatitis
ea0025p51
An unusual goitre
ea0025p52
Echocardiogram in prolactinoma patients taking ergot derived dopamine agonists
ea0025p53
Management of adrenal incidentaloma: are we getting it right?
ea0025p54
Hypoadrenalism then adrenal haemorrhage as manifestation of lymphoma relapse after 3.5 years
ea0025p55
Hormone profile of patients referred for Bariatric surgery
ea0025p56
Effective use of Cinacalcet in tertiary hyperparathyroidism in a patient with hypophosphataemic rickets
ea0025p57
Long-term single centre outcome of phaeochromocytoma/paraganglioma
ea0025p58
An analysis of false positive urinary catecholamine and metabolite results in a tertiary endocrine centre
ea0025p59
Juxta-adrenal Schwannoma presenting as 'Giant' adrenal adenoma
ea0025p60
Life-threatening adverse reaction following pituitary MRI
ea0025p61
Audit on colonoscopy screening in acromegaly patients in a tertiary endocrine unit
ea0025p62
Adrenal haemorrhage associated with therapeutic Clexane and subtherapeutic warfarin
ea0025p63
A case of SIADH and hyponatremia treated successfully with Tolvaptan
ea0025p64
Proton pump inhibitor (PPI) therapy in patients admitted to a diabetes and endocrine medical ward: are there clear indications?
ea0025p65
Pituitary thyroid hormone resistance (PTHR)
ea0025p66
Status epilepticus in addisonian crisis
ea0025p67
Improving communication in clinical care: a re-audit of an Endocrinology and Diabetes GP e-mail advisory service following commissioning
ea0025p68
Hyponatraemia in a patient presenting with diabetic ketoacidosis: a case of polyglandular autoimmune syndrome type 2
ea0025p69
Sweating is only half the story
ea0025p70
Does the glucagon challenge test add to the utility of a 72 h fast for spontaneous hypoglycemia?
ea0025p71
Thyroid swelling and tracheal compression: a cautionary tale
ea0025p72
Introduction of day-case thyroid and parathyroid surgery has allowed achievement of the shortest length-of-stay in the United Kingdom
ea0025p73
Ectopic prolactinoma in a patient with a clivoid mass
ea0025p74
Prevalence and prediction of endocrinopathies in thalassaemia major
ea0025p75
Significant hirsutism complicating pregnancy with postpartum resolution
ea0025p76
A case of cerebral salt wasting syndrome
ea0025p77
Milk-alkali syndrome: not to be forgotten
ea0025p78
A case of lymphocytic hypophysitis
ea0025p79
Targets for improvement of care for thyroid carcinoma patients in the multidisciplinary setting
ea0025p80
Use of Tolvaptan in hyponatraemia: how long is treatment required?
ea0025p81
The thyroid and the skin
ea0025p82
An unusual case of medullary thyroid cancer presented with T3 toxicosis and type 2 diabetes
ea0025p83
Tramadol-induced adrenal insufficiency. A case report.
ea0025p84
A case of carcinoid syndrome due to medullary thyroid carcinoma
ea0025p85
Calcitonin negative medullary thyroid cancer
ea0025p86
A case of complete androgen insensitivity syndrome (CAIS), late presentation and difficult management
ea0025p87
'Old Red-Eyes Is Back': a case of calcium-alkali syndrome
ea0025p88
Congenital adrenal hyperplasia: spontaneous resolution or cure?
ea0025p89
Multiple endocrine dysfunction in the context of psychiatric medication
ea0025p90
Primary care records in hospital clinics: implementing two-way communication in Cheshire, UK
ea0025p91
Thyroid function monitoring in amiodarone treated patients: the need to increase awareness among prescribing physicians
ea0025p92
Psychiatric illness: a cause and hurdle to management of nephrogenic diabetes insipidus
ea0025p93
Pseudo-Cushing's syndrome and central pontine myelinolysis
ea0025p94
Cyclical Cushing's or poorly controlled diabetes in an insulin resistant patient?
ea0025p95
Recreational jaundice
ea0025p96
Hypercalcaemia following parathyroidectomy in a pregnant lady with MEN-1
ea0025p97
Disappearing adrenal insufficiency
ea0025p98
Metastatic insulinoma in a patient with type 2 diabetes mellitus: case report
ea0025p99
The beneficial effects of long-acting octreotide in a patient with concomitant metastatic neuroendocrine tumour and anaemia due to lower digestive bleeding
ea0025p100
Thyroid storm in a teacup: an unusual presentation of thyrotoxicosis Category: clinical practice/governance and case reports
ea0025p101
Hyponatraemia and SIADH as a presenting feature of acquired immunodeficiency syndrome
ea0025p102
Testosterone undecanoate has a beneficial effect on lipid profile in men with hypogonadism in routine clinical practice
ea0025p103
Unwanted recovery from secondary hypogonadism: paradoxical effect of Zoladex
ea0025p104
Review of 125 individuals with adrenal incidentalomas: a single centre cohort
ea0025p105
Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases
ea0025p106
Study of serum prolactin and cardiovascular risk in patients with type 2 diabetes mellitus
ea0025p107
Identifying patients with familial hypercholesterolaemia and evaluating management locally
ea0025p108
Cytokines, growth factors, neuroendocrinology and behaviour
Altered corticosterone homeostatsis in hippocampus leads to memory impairment in hypobaric hypoxia
ea0025p109
Selected adipocytokines serum levels in patients with ischemic stroke
ea0025p110
Abstract unavailable
ea0025p111
Characterisation of the stress-response in BACE1 heterozygous mice
ea0025p112
Salivary cortisol monitoring in sheep and cows: evidence for acute activation of the hypothalamo-pituitary-adrenal (HPA) axis using two models of stress
ea0025p113
The effects of recombinant human IGF1/IGF binding protein-3 on body composition and physical fitness in recreational athletes
ea0025p114
The effects of recombinant human IGF1/IGF binding protein-3 on lipid and glucose metabolism in recreational athletes
ea0025p115
Hypothalamic tanycytes express nuclear receptor regulating enzymes in the absence of mRNA transcript
ea0025p116
Differential regulation of the neurotrophins, NGF and BDNF, and their receptors in the myometrium of women affected by adenomyosis
ea0025p117
Impact of synovial fibroblasts on adipose tissue
ea0025p118
Cytokine profiling of pre-diabetic patients
ea0025p119
Diabetes, metabolism and cardiovascular
Inflammatory markers are not strongly associated with the metabolic syndrome in type 2 DM
ea0025p120
Renal ischemia/reperfusion injury in type II DM: possible role of proinflammatory cytokines, apoptosis, and nitric oxide
ea0025p121
Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profile
ea0025p122
The effects of Syzygium aromaticum derived oleanolic acid on glycogenic enzymes in streptozotocin induced-diabetic rats
ea0025p123
Serum 25-hydroxy-vitamin D is associated with adiponectin and insulin resistance in diabetic Saudi adults
ea0025p124
Endoplasmic reticulum oxidoreductases and insulin folding
ea0025p125
Does the effect of non-alcoholic fatty liver disease confer increased cardiovascular risk in patients with polycystic ovary syndrome?
ea0025p126
Utility of glycated haemoglobin in diagnosing prediabetes in Asian Indians- A Community Survey: Chandigarh Urban Diabetes Study (CUDS) group
ea0025p127
Safety profile of Vildagliptin in clinical practice: 2-year data from 2 Tertiary hospitals
ea0025p128
Sound mind, but sweet blood: olanzapine induced hyperglycaemia
ea0025p129
Cabergoline prevents weight gain in patients evaluated for hyperprolactinaemia
ea0025p130
Interactions between glucagon and GLP-1 in neuronal pathways affecting food intake
ea0025p131
The effect of environmental enrichment on food intake, body weight and the HPA axis in laboratory rats
ea0025p132
Plasma Annexin A1 (AnxA1) is inversely correlated with waist to hip ratio in healthy males
ea0025p133
Abstract unavailable
ea0025p134
Characterisation of IGFBP1 molecular forms in healthy persons and patients with diabetes mellitus type 2 or hypoglycemia
ea0025p135
The Megalin-Cubilin receptor-mediated endocytic pathway is impaired in Dent's disease renal proximal tubule cell-lines
ea0025p136
Influence of metabolic decompensation in children with diabetes mellitus type 1 on changes of QT interval
ea0025p137
Hypogonadism with subsequent multi-organ involvement: a mystery solved
ea0025p138
Pomegranate juice consumption influences urinary glucocorticoids, attenuates blood pressure and exercise-induced oxidative stress in healthy volunteers
ea0025p139
Insulin sensitivity and cytokine response to different exercise modalities in hypoxia in type 2 diabetics
ea0025p140
Audit of short synacthen tests in patients with type 2 diabetes mellitus
ea0025p141
Retinal screening in pregnant women with diabetes: 'are we doing enough'
ea0025p142
Insulin-mediated pseudoacromegaly
ea0025p143
Brain natriuretic peptide rises with exercise at high altitude and is associated with acute mountain sickness scores
ea0025p144
Diet-induced obesity with metabolic dysfunction does not alter vascular function or remodelling in young C57Bl/6 mice
ea0025p145
Postprandial hypertriglyceridaemia in patients with polycystic ovary syndrome
ea0025p146
Abstract unavailable
ea0025p147
Continuous feeding in rats: a novel paradigm for inducing hypocaloric obesity?
ea0025p148
Improvement of cardiovascular risk factors 12 months after Roux-en-Y surgery
ea0025p149
The prevalence of non alcoholic fatty liver disease in GH deficiency and the effect of GH replacement
ea0025p150
Serum erythropoietin levels in patients with acute myocardial infarction
ea0025p151
Low testosterone and severity of erectile dysfunction (ED) are independently associated with poor health related quality of life (HRQoL) in men with type 2 diabetes
ea0025p152
Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases
ea0025p153
Over-expression of iodothyronine deiodinase III in the hypothalamic VMN as a potential model of local hypothyroidism
ea0025p154
The effect of glucose on hypothalamic neuropeptide Y release investigated using static incubation of hypothalamic explants
ea0025p155
Attenuated atherosclerosis in 11[beta]-hydroxysteroid dehydrogenase type 1 deficient ApoE-/- mice is associated with reduced aortic VCAM-1 expression and reduced MCP-1 in the visceral fat
ea0025p156
Study of serum prolactin and cardiovascular risk in patients with type 2 diabetes mellitus
ea0025p157
Effect of diet/lifestyle advice on weight change in an unselected polycystic ovary syndrome (PCOS) population
ea0025p158
Investigating the effects of testosterone on inflammatory markers of early aortic atherosclerosis in the testicular feminised mouse (Tfm) model
ea0025p159
Study of the adipocytokine visfatin in obesity and type 2 diabetes mellitus
ea0025p160
Study of lipoprotein phospholipase A2 as a biomarker for cardiovascular events in type 2 diabetes mellitus
ea0025p161
Serum 25-hydroxyvitamin D3 concentrations and cardiovascular risk among type 2 diabetic patients
ea0025p162
Low testosterone predicts increased mortality and testosterone replacement therapy improves survival in men with type 2 diabetes
ea0025p163
Chronic GH excess is associated with adenosine monophosphate-activated protein kinase (AMPK) threonine-172 phosphorylation changes that do not lead to changes in AMPK activity
ea0025p164
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study
ea0025p165
Lack of beneficial metabolic profile in liver-specific 11[beta]-hydroxysteroid dehydrogenase type 1 (11[beta]-HSD1) knockout mice
ea0025p166
Defining multipotent progenitors in the human fetal pancreas by expression and ChIP-seq
ea0025p167
Endocrine tumours and neoplasia
Ectopic ACTH syndrome: experience of a tertiary referral centre: from diagnosis to outcome
ea0025p168
Ovarian steroid cell tumour in association with Von Hippel--Lindau disease
ea0025p169
Simplified minimally invasive parathyroidectomy: a series of 100 cases and a review of the literature
ea0025p170
'Uterine neuroendocrine tumour: an unusual cause of hyponatraemia' and the role of tolvaptan, a vasopressin V2 receptor antagonist
ea0025p171
Toll receptor-mediated inflammatory system is present in tumour cells from endocrine-related tissues
ea0025p172
Adenosine receptors modulate chromogranin A secretion and growth of neuroendocrine tumours: potential targets for therapy
ea0025p173
Low rate of recurrence after excision of non-familial phaeochromocytomas
ea0025p174
Phaeochromocytoma presenting as polycythaemia
ea0025p175
Development and validation of a LC-MS/MS method for the measurement of plasma renin activity using on-line solid phase extraction
ea0025p176
Clinical and biochemical features of sporadic and hereditary phaeochromocytomas and paragangliomas: an analysis of 47 cases investigated in a single centre
ea0025p177
Metastatic insulinoma treated by transhepatic arterial embolisation
ea0025p178
Pro-opiomelanocortin is a marker of liver and brain metastases from small cell lung cancer xenografts
ea0025p179
Prevalence of functionality in adrenal incidental masses
ea0025p180
Laparoscopic adrenalectomy for Conn's syndrome benefits is beneficial to patients and to health finances
ea0025p181
A rare case of calcitonin and carcinoembryonic antigen negative medullary thyroid cancer
ea0025p182
Endocrine disorders in adults treated for Hodgkin lymphoma in childhood
ea0025p183
Parathyroid carcinoma: an important differential diagnosis in primary hyperparathyroidism
ea0025p184
A patient with adrenal carcinoma
ea0025p185
Adrenal incidentaloma: how frequently do adrenal incidentalomas cause problems in terms of hormone hypersecretion or tumour growth?
ea0025p186
Phaeochromocytoma, paraganglioma and tumour genetics: clinical practice lagging theory?
ea0025p187
Clinical outcomes of adrenal incidentalomas over a 3 year period: a retrospective analysis to evaluate a new referral pathway
ea0025p188
Pituitary apoplexy: headache and beyond
ea0025p189
Adrenal incidentalomas: should we be doing PET scans?
ea0025p190
Endocrine neoplastic manifestations of neurofibromatosis type 1 (NF1): a case and discussion
ea0025p191
Familial adrenocortical carcinoma associated with HNPCC
ea0025p192
Prevalence and follow-up of adrenal incidentalomas after CT renal colic
ea0025p193
Bowel obstruction can be the presenting symptom of phaeochromocytoma
ea0025p194
PBF is induced by ionising radiation and functionally inactivates p53 in thyroid cancer
ea0025p195
MEN-1 mosaic: the founder of a family
ea0025p196
Rare association of simultaneous adrenal Cushing's and primary hyperparathyroidism in patient with previous Graves disease
ea0025p197
PTTG and PBF: targets for enhancement of radioiodine uptake in thyroid tumours
ea0025p198
A case of phaeochromocytoma of the urinary bladder
ea0025p199
An atypical presentation of primary hyperparathyroidism
ea0025p200
Insulinoma presenting as post-prandial hypoglycaemia
ea0025p201
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a precursor to pulmonary carcinoid
ea0025p202
Five year experience of investigation and management of histologically proven chromaffin cell tumours
ea0025p203
Growth and development
Association between plasma steroid hormone level, growth and obesity in adolescent girls
ea0025p204
Identification of turner syndrome specific mRNA expression profiles that correlate with clinical response to growth hormone
ea0025p205
Effects of the prenatal environment on haematological and skeletal muscle parameters in one-week-old piglets: a role for glucocorticoids?
ea0025p206
Genetic characterisation of primary GH Insensitivity (GHI) presenting as growth failure: 10 years experience at the Centre for Endocrinology, William Harvey Research Institute, Barts and the London
ea0025p207
The use of a novel injection delivery system to address compliance in patients receiving GH replacement therapy
ea0025p208
Nursing practise
Audit of low dose dexamethasone suppression test to exclude androgen secreting tumours in hyperandrogenic women
ea0025p209
Care of cancer survivors: the role of endocrinologists
ea0025p210
Nebido (testosterone undecanoate) in patients over 60 years of age: a time to reduce dose frequency?
ea0025p211
Diagnosis denial exacerbated by thyrotoxicosis
ea0025p212
Cushing's syndrome due to ectopic ACTH secretion from a hepatic neuroendocrine tumour
ea0025p213
An unusual complication in a patient with Graves' disease
ea0025p214
What is the appropriate time for radioactive iodine re-dosing to achieve cure of persistent hyperthyroidism?
ea0025p215
A comparison between post-radioiodine outcomes following the use of two different fixed-dose regimes
ea0025p216
Use of plasma metanephrine estimation in the diagnostic work-up of phaeochromocytoma: an audit of local practice
ea0025p217
Bilateral testicular tumours, a case of mistaken identity?
ea0025p218
Low bone mass is an infrequent long-term sequelea of pituitary disease
ea0025p219
Joint radioiodine clinic - patient satisfaction survey
ea0025p220
Assessment of bone density in patient with adrenal insufficiency
ea0025p221
Pituitary
Has you appearance changed over the last few years? Oh I'm really ugly now!
ea0025p222
Mortality in cushing's disease: stoke-on-trent data and meta-analysis
ea0025p223
Negotiating with a pea-sized hormone factory: the mediatory role of pituitary formyl peptide receptor (FPR) ligands in times of stress
ea0025p224
Pituitary dysfunction is uncommon in pituitary incidentalomas
ea0025p225
A case of lymphocytic hypophysitis with spontaneous remission
ea0025p226
An unusual cause of a sellar mass presenting as a pituitary adenoma
ea0025p227
An audit of 220 insulin tolerance tests
ea0025p228
20 year experience in the surgical management of cushing's disease in a UK tertiary referral centre
ea0025p229
Suspected spontaneous resolution of pituitary cushing's disease
ea0025p230
Tri-phasic changes in sodium levels post pituitary surgery
ea0025p231
Rare case of disseminated adenocarcinoma prostate metastasising to the pituitary, with a normal PSA
ea0025p232
An unusual case of extremely high prolactin due to stalk disconnection hyperprolactinaemia
ea0025p233
The risk of cardiac valvulopathy in cabergoline-treated endocrine patients in a district general hospital
ea0025p234
Cancer stem cells with a stabilising mutation in beta-catenin are implicated in the aetiology of human adamantinomatous craniopharyngioma
ea0025p235
Long term morbidities in a large series of patients with Cushing's disease
ea0025p236
Molecular and functional characterisation of an endocannabinoid system in L[beta]T2 gonadotrophs
ea0025p237
Assessment of the feasibility of early hospital discharge following trans-sphenoidal pituitary surgery
ea0025p238
A debilitating case of cushing's disease?
ea0025p239
Cranial nerve palsy related to previous radiotherapy in a treated case of acromegaly
ea0025p240
Worsening of thyroid functions following surgical removal of a combined GH/TSHoma
ea0025p241
Pitfalls in transphenoidal surgery: a 10 years experience
ea0025p242
Pituitary apoplexy is a rare endocrine emergency, historically confused with other acute medical conditions, which delayed the diagnosis, however with advances in brain imaging, diagnosing this condition is much easier
ea0025p243
BAC recombineering to understand the role of the alternative promoter in the regulation of prolactin expression
ea0025p244
Evaluation of the interaction of phosphodiesterases 2A and 4A5 with the aryl hydrocarbon receptor interacting protein in pituitary cells
ea0025p245
SIADH of cancer: rapid diagnostic evaluation using copeptin as a marker of AVP
ea0025p246
Hypopituitarism: is it due to bacterial meningitis?
ea0025p247
Thyroid function in patients with pituitary disease: difficulties of individualisation
ea0025p248
Prospective assessment of pituitary function in patients with macroprolactinoma treated with cabergoline
ea0025p249
Delivery of anti-POMC siRNA using a novel polymer
ea0025p250
Structure and function of lactotrophs in the anterior pituitary of TPC1 null mice
ea0025p251
An uncommon cause of panhypopituitarism
ea0025p252
Associations of overall GH and IGF1 exposure with ischaemic heart disease and cardiomyopathy in patients with treated acromegaly
ea0025p253
Overall GH exposure is raised in acromegalic patients with type 2 diabetes and impaired glucose tolerance, when compared with euglycaemic acromegalic patients
ea0025p254
Morphological analysis of lactotrophs in pregnant and lactating mice
ea0025p255
Hypertrophic pachymeningitis and pituitary pathology: lymphocyctic hypophysitis or cabergoline related fibrosis?
ea0025p256
Thyroid function in patients with pituitary disease: difficulties of individualisation
ea0025p257
An unusual presentation of thyrotroph adenoma
ea0025p258
Wide range of eye abnormalities in patients with hypopituitarism; implications for diagnosis and treatment
ea0025p259
Abstract unavailable
ea0025p260
Lymphocytic hypophysitis-extrapancreatic manifestation of autoimmune pancreatitis
ea0025p261
Elusive ectopic ACTH source
ea0025p262
Reproduction
Endocrine disruptors and their association with male reproductive disorders and testicular dysgenesis syndrome: establishing a xenografting model of human fetal testis development
ea0025p263
Distinct expression pattern of Dicer1 correlates with ovarian-derived steroid hormone receptors in human Fallopian tubes during the ovulatory process and in the mid-secretory phase.
ea0025p264
The effect of atorvastatin on adrenal and ovarian hyperandrogenemia in patients with polycystic ovary syndrome.
ea0025p265
Abstract unavailable
ea0025p266
Placental iodothyronine deiodinase activity across the placental bed in normotensive (NT) and pre-eclamptic (PE) pregnancies.
ea0025p267
In support of the 'Rotterdam' PCOS criteria: Identical LH responses to GnRH stimulation in women with oligo-/amenorrhoea and polycystic ovaries regardless of androgen status
ea0025p268
Kisspeptin-54 injection stimulates activity of the human GnRH pulse generator in healthy women
ea0025p269
Expression and functional activity of thyroid hormone transporters in microvillous plasma membranes from human term placental syncytiotrophoblasts
ea0025p270
Increased epididymal Rnase9 expression in Rnase10 (-/-) mice
ea0025p271
Is age of vaginal opening an indicator of leptin sensitivity in female Sprague Dawley rats?
ea0025p272
A case of severe refractory hypercalcaemia in pregnancy caused by hypersecretion of parathyroid hormone related peptide (PTHrP) by the placenta.
ea0025p273
Comparison of cardiovascular markers and variability of insulin resistance in women with anovulatory and ovulatory polycystic ovary syndrome
ea0025p274
Male germ cell activity during perinatal reproductive development in the mouse
ea0025p275
Defining insulin signalling pathways in granulosa-lutein (GL) cells in women with polycystic ovary syndrome (PCOS)
ea0025p276
Increased intensity of P450c17 protein expression in theca cells from polycystic ovaries
ea0025p277
Neuromedin B stimulates the hypothalamo-pituitary-gonadal axis in male rats
ea0025p278
Nesfatin stimulates the hypothalamic-pituitary-gonadal axis in male rats
ea0025p279
Study of role of retinol-binding protein 4 in women with polycystic ovary syndrome
ea0025p280
HRPE773 (ZG16B) expression is elevated in human endometrium during the early secretory phase of the menstrual cycle and in uterine decidua following miscarriage
ea0025p281
Case-control study of 5-alpha reductase type 2 Val89Leu polymorphism in Romanian PCOS patients
ea0025p282
Steroids
GPs say they rely on endocrinologists to manage adrenal crisis and patient education for Addison's disease
ea0025p283
Dehydroepiandrosterone (DHEA) supplementation improves cognitive function in perimenopausal rhesus monkeys
ea0025p284
Measurement of salivary testosterone in female samples using a highly sensitive LC-MS/MS assay
ea0025p285
Steroid Replacement Education: Impact on Patients and their Carers
ea0025p286
How reproducible are LC-MS testosterone results? A calibration exercise
ea0025p287
The effect of prednisolone on different cortisol methods
ea0025p288
Glucocorticoid receptor antagonism as a decision making tool in patients with adrenal incidentaloma and low-grade excess cortisol secretion: a pilot study
ea0025p289
Urinary tetrahydroaldosterone excretion is determined by rising urinary sodium excretion in patients with chronic kidney disease
ea0025p290
Urinary tetrahydrodeoxycorticosterone excretion is a significant independent predictor of LV mass in patients with chronic kidney disease
ea0025p291
Glycyrrhetinic acid disrupts the synthesis of adrenocorticosteroid hormones at multiple sites
ea0025p292
Clinical outcomes of 250 [mu]g short synacthen tests in a tertiary referral centre
ea0025p293
Cortisol decreases lipogenesis in human hepatocytes
ea0025p294
Systems biology reveals a novel mechanism regulating glucocorticoid action
ea0025p295
Spitting out the issues: Identifying optimal procedures for saliva collection and storage
ea0025p296
Effects of endocrine disruptors in adult rats: integrative evaluation from gonadal steroidogenic gene expression profiles to hormonal balance
ea0025p297
An unusual case of hypoadrenalism presenting with hypercalcaemia following severe Legionella sepsis
ea0025p298
A retrospective analysis of Short Synachthen Tests to assess the effect of a change in the normal reference range
ea0025p299
Concurrent analysis of 10 serum steroids by mass spectrometry: investigation of the viability of the Perkin-Elmer CHS[trade] MSMS steroids kit on a waters xevo mass spectrometer with acquity UPLC system
ea0025p300
An atypical case of familial glucocorticoid deficiency without pigmentation caused by coexistent homozygous mutations in MC2R (T152K) and MC1R (R160W)
ea0025p301
Cushing's syndrome in a patient with two lung tumours
ea0025p302
Accidental long-term ingestion of androgenic steroid in a young female: a case report
ea0025p303
Exogenous Cushing's syndrome due to topical corticosteroid application
ea0025p304
Is there a threshold morning cortisol level at which to perform the short synacthen test?
ea0025p305
Why does MRAP2 fail to save familial glucocorticoid deficiency type 2 patients?
ea0025p306
Epidemiology of Addison's disease in the area of banbury, oxfordshire
ea0025p307
Derivatisation of estrogens enhances sensitivity of analysis by liquid chromatography tandem mass spectrometry
ea0025p308
Utility of basal DHEAS measurement in the detection of subclinical autonomous glucocorticoid hypersecretion in adrenal incidentaloma
ea0025p309
Effects of topical betamethasone and calcipotriol therapy in improving the tolerogenic potential of a 'vaccine' for type 1 diabetes
ea0025p310
Hepatic 11[beta]-hydroxysteroid dehydrogenase type 1 expression is dynamically related across the liver lobule and is linked to metabolic status
ea0025p311
Thyroid
Prevalence of overt and subclinical hypothyroidism among Saudi pregnant women attending tow referral hospitals in Saudi Arabia and associated maternal and fetal complications
ea0025p312
Hashimoto's encephalopathy: an unusual cause for coma
ea0025p313
Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy
ea0025p314
Outcomes of radioactive iodine treatment for hyperthyroidism: 1 year follow up survey in subjects attending a general hospital endocrine clinic
ea0025p315
The mystery of persistent thyrotoxicosis
ea0025p316
Anaplastic thyroid carcinoma presenting with stridor after ablative radioiodine therapy for Graves' disease
ea0025p317
Serum phosphate predicts temporary hypocalcaemia following thyroidectomy
ea0025p318
Audit on follow up of thyroid function tests done during osteoporosis screening
ea0025p319
Serum homocysteine concentrations in hypothroid, euthyroid and hyperthyroid patients
ea0025p320
PTTG-binding factor (PBF) induces hyperplastic lesions in thyroids of aged mice
ea0025p321
Does the introduction of a pregnancy-specific TSH reference range improve the increases in management of treated hypothyroidism during pregnancy?
ea0025p322
Spectrum of thyroid dysfunction in interferon-[alpha] treated hepatitis C-positive patients
ea0025p323
Effect of weight loss through gastric bypass on thyroid function in euthyroid people with morbid obesity
ea0025p324
Iodine induced thyrotoxicosis: the danger of over the counter slimming aids
ea0025p325
The effect of parathyroidectomy on neuropsychological symptoms in patients with asymptomatic primary hyperparathyroidism
ea0025p326
Management of hyperfunctioning thyroid malignancy with psychiatric co-morbidity
ea0025p327
Thyrotoxic crisis: a stormy period on intensive care
ea0025p328
Hypothyroidism and adrenaleukodystrophy, a rare association
ea0025p329
Should individuals with a Thy 3 result always undergo surgery?
ea0025p330
The natural history of endogenous subclinical hyperthyroidism
ea0025p331
A case of amiodarone induced thyrotoxicosis, type II followed by subsequent hypothyroidism
ea0025p332
Audit of thyroid function testing in patients on amiodarone
ea0025p333
Depot specific differences in regulation of hyaluronan production of relevance to Graves' orbitopathy
ea0025p334
The use of tandem mass spectrometry to identify binding partners of PBF in thyroid cells
ea0025p335
Variation in levels of skewed X chromosome inactivation represents a shared pathogenic pathway for the common autoimmune thyroid diseases
ea0025p336
Seasonal variation in thyroid autoimmunity as assessed by anti-thyroid peroxidase antibodies is related to temperature
ea0025p337
A case of Graves' disease associated with severe hypercalcaemia
ea0025p338
Thyroid hormone receptor alpha is a permissive factor that regulates osteoclastogenesis indirectly
ea0025p339
Targeted hPTTG overexpression in vivo induces reduced cellular proliferation and p53 stabilisation resulting in decreased thyroid size
ea0025p340
What is the influence of rheumatologic conditions on response to medical therapy of Graves' disease?
ea0025p341
Hashimoto's thyroiditis with associated neurological deficits (Hashimoto's encephalopathy)
ea0025p342
Optimal use of thyroid antibody assays in the identification of auto-immune thyroid disease
ea0025p343
Thyroid hormone changes and psychological response to high altitude stress: effect of ethnicity
ea0025p344
Study of serum adiponectin and leptin in a cohort of Egyptian women with thyroid dysfunction
ea0025p345
Changes in urinary fractional excretion (FE) of calcium and phosphate following treatment of hyperthyroid cats
ea0025p346
Retrospective analysis of thyroid fine needle aspiration (FNA) in a tertiary hospital
ea0025p347
Weight gain following treatment of hyperthyroidism depends on gender and disease severity but not on the treatment administered
ea0025p348
A novel prospective ocular manifestation of Graves' disease
ea0025p349
Sialorrhoea: an uncommon symptom of Graves' disease
ea0025p350
Thyroid dysfunction in patients receiving interferon treatment for hepatitis C: an audit
ea0025p351
Variation in free T3 (fT3) within the reference range is associated with bone development in children, and mediated via alteration in body mass indices
ea0025p352
Langerhans cell histiocytosis of the thyroid gland -does it needs prophylactic thyroidectomy?
ea0025p353
Generalised anxiety disorder following thyroidectomy
ea0025p354